語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
FindBook
Google Book
Amazon
博客來
Cell States and Therapeutic Targets in Pancreatic Cancer.
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Cell States and Therapeutic Targets in Pancreatic Cancer./
作者:
Guo, James.
面頁冊數:
1 online resource (197 pages)
附註:
Source: Dissertations Abstracts International, Volume: 84-12, Section: B.
Contained By:
Dissertations Abstracts International84-12B.
標題:
Biology. -
電子資源:
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30485212click for full text (PQDT)
ISBN:
9798379614713
Cell States and Therapeutic Targets in Pancreatic Cancer.
Guo, James.
Cell States and Therapeutic Targets in Pancreatic Cancer.
- 1 online resource (197 pages)
Source: Dissertations Abstracts International, Volume: 84-12, Section: B.
Thesis (Ph.D.)--Harvard University, 2023.
Includes bibliographical references
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer wherein treatment resistance is common and survival is poor. Prior transcriptional profiling studies have revealed two major cell states in untreated human PDAC - classical and basal-like - with differential prognoses and clinical responses to treatment. As such, transcriptional cell states have been the subject of considerable investigation in the pancreatic cancer field over the past decade. While the basal-like vs. classical classification can inform prognosis, many patients with localized disease receive upfront chemotherapy prior to surgery, and most patients enrolled on clinical trials have likely received prior chemotherapy. We therefore sought to understand whether and how treatment alters the transcriptional cell state taxonomy and performed single-nucleus RNA-seq and spatial mRNA profiling on primary tumors treated with or without neoadjuvant chemotherapy and radiation. In doing so, we discovered the existence of a novel 'neural-like progenitor' cancer cell state which was significantly enriched in treated cancer cells, and found that it is regulated by GLIS3, a transcription factor canonically involved in neuroendocrine lineage specification. We next sought to functionally investigate the biology of the classical, basal-like, and neural-like cell states through the development of ex vivo and in vivo isogenic models driven by transcription factor overexpression. This revealed distinct morphologies, in vivo growth kinetics, metastatic proclivities, and drug sensitivities associated with each cell state. Furthermore, cell-intrinsic gene expression patterns were associated with cell-extrinsic microenvironmental features; for instance, the neural-like cancer state was enriched with a gene signature for perineural invasion. Finally, we leveraged functional genetic screens in cell lines and patient-derived organoids to survey novel or underexplored therapeutic targets for this devastating disease. Together, our findings improve our understanding of the biology of cancer cell states and provide guidance for future target validation efforts in pancreatic cancer.
Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023
Mode of access: World Wide Web
ISBN: 9798379614713Subjects--Topical Terms:
522710
Biology.
Subjects--Index Terms:
Aggressive cancerIndex Terms--Genre/Form:
542853
Electronic books.
Cell States and Therapeutic Targets in Pancreatic Cancer.
LDR
:03499nmm a2200397K 4500
001
2363957
005
20231127094744.5
006
m o d
007
cr mn ---uuuuu
008
241011s2023 xx obm 000 0 eng d
020
$a
9798379614713
035
$a
(MiAaPQ)AAI30485212
035
$a
AAI30485212
040
$a
MiAaPQ
$b
eng
$c
MiAaPQ
$d
NTU
100
1
$a
Guo, James.
$3
3704736
245
1 0
$a
Cell States and Therapeutic Targets in Pancreatic Cancer.
264
0
$c
2023
300
$a
1 online resource (197 pages)
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
500
$a
Source: Dissertations Abstracts International, Volume: 84-12, Section: B.
500
$a
Advisor: Aguirre, Andrew J.
502
$a
Thesis (Ph.D.)--Harvard University, 2023.
504
$a
Includes bibliographical references
520
$a
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer wherein treatment resistance is common and survival is poor. Prior transcriptional profiling studies have revealed two major cell states in untreated human PDAC - classical and basal-like - with differential prognoses and clinical responses to treatment. As such, transcriptional cell states have been the subject of considerable investigation in the pancreatic cancer field over the past decade. While the basal-like vs. classical classification can inform prognosis, many patients with localized disease receive upfront chemotherapy prior to surgery, and most patients enrolled on clinical trials have likely received prior chemotherapy. We therefore sought to understand whether and how treatment alters the transcriptional cell state taxonomy and performed single-nucleus RNA-seq and spatial mRNA profiling on primary tumors treated with or without neoadjuvant chemotherapy and radiation. In doing so, we discovered the existence of a novel 'neural-like progenitor' cancer cell state which was significantly enriched in treated cancer cells, and found that it is regulated by GLIS3, a transcription factor canonically involved in neuroendocrine lineage specification. We next sought to functionally investigate the biology of the classical, basal-like, and neural-like cell states through the development of ex vivo and in vivo isogenic models driven by transcription factor overexpression. This revealed distinct morphologies, in vivo growth kinetics, metastatic proclivities, and drug sensitivities associated with each cell state. Furthermore, cell-intrinsic gene expression patterns were associated with cell-extrinsic microenvironmental features; for instance, the neural-like cancer state was enriched with a gene signature for perineural invasion. Finally, we leveraged functional genetic screens in cell lines and patient-derived organoids to survey novel or underexplored therapeutic targets for this devastating disease. Together, our findings improve our understanding of the biology of cancer cell states and provide guidance for future target validation efforts in pancreatic cancer.
533
$a
Electronic reproduction.
$b
Ann Arbor, Mich. :
$c
ProQuest,
$d
2023
538
$a
Mode of access: World Wide Web
650
4
$a
Biology.
$3
522710
650
4
$a
Cellular biology.
$3
3172791
650
4
$a
Oncology.
$3
751006
650
4
$a
Medical imaging.
$3
3172799
653
$a
Aggressive cancer
653
$a
Cell states
653
$a
Chemotherapy
653
$a
Pancreatic cancer
655
7
$a
Electronic books.
$2
lcsh
$3
542853
690
$a
0306
690
$a
0379
690
$a
0574
690
$a
0992
710
2
$a
ProQuest Information and Learning Co.
$3
783688
710
2
$a
Harvard University.
$b
Biology, Molecular and Cellular.
$3
2093132
773
0
$t
Dissertations Abstracts International
$g
84-12B.
856
4 0
$u
http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30485212
$z
click for full text (PQDT)
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9486313
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入